Please use this identifier to cite or link to this item:
Title: The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
Issue Date: Jul-2016
Citation: Arch. Dis. Child. Fetal Neonatal Ed..2016 Jul;(101)4:F333-8
Abstract: The SafeBoosC phase II randomised clinical trial recently demonstrated the benefits of a combination of cerebral regional tissue oxygen saturation (rStO2) by near-infrared spectroscopy (NIRS) and a treatment guideline to reduce the oxygen imbalance in extremely preterm infants.
PMID: 26645538
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC4941140.pdf818.19 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.